Here, the administration of a novel endogenous poly-peptide, designated neonatal NET-inhibitory factor (nNIF) [438], in experimental stroke models improved long-term neurological and motor function as well as enhanced survival after stroke [80]. The gene discussed is SERPINA1; the disease is stroke disorder.